Tagged Articles

overweight 27 articles

FDA approves new diet pill Contrave

A new prescription diet pill has been given clearance by the Food and Drug Administration (FDA) for marketing in the United States. Contrave, made by Orexigen Therapeutics, is a combination of bupropion, an antidepressant that is also used for smoking cessation, and naltrexone, a drug used to treat drug and alcohol dependence. Contrave is approved for overweight or obese patients with a body mass index (BMI) of 30 or higher, as well as people with a BMI of 27 or higher with at least one other health issue such as diabetes. Patients treated with Contrave lost an average of 4.2 ... Read More

Whole Foods to pay $800,000 for overcharging California customers

Whole Foods Market agreed to pay $800,000 in penalties and remain under firm oversight for five years after California officials determined the grocer was overcharging customers throughout the state. The Santa Monica City Attorney’s Office said that state and local investigators conducted a yearlong investigation that found “widespread pricing violations” in the stores owned and operated by the Austin, Texas, organic grocer. Investigators said that Whole Foods had been overcharging its customers in various ways including charging customers the weight of containers for self-serve (salad bar, hot bar, etc.) and unpackaged bulk foods rather than deducting the weight as required ... Read More

Type 2 diabetes drug Victoza tested as potential diet drug

The type 2 diabetes drug Victoza (liraglutide) can help overweight and obese people without diabetes lose weight, according to a new multinational clinical trial, but the drug comes with some risks. Victoza, an injectable drug in a class of diabetes medications known as glucagonlike peptide-1 (GLP-1) agonist, was approved by the Food and Drug Administration (FDA) in January 2010 to help lower blood sugar levels in people with type 2 diabetes. In an effort to expand the indication to non-diabetics who are overweight, the medication was pitted against a placebo and the currently marketed anti-obesity drug Qsymia, a combination of ... Read More

Medical groups want children to have their cholesterol levels checked

Children ages 9-11 should have their cholesterol levels checked by their pediatricians, recommends the National Heart, Lung and Blood Institute. High cholesterol doesn’t just affect adults, it can occur in children as well. And it’s not always associated with obesity. By checking cholesterol levels in kids, doctors can identify risk factors early on to reduce their risk of heart disease as adults. The American Academy of Pediatrics recommends that children be screened after age 2 but no later than age 10. If the fasting lipid profile is normal, the test need not be repeated for another three to five years. ... Read More

Extra weight carries no health benefit for diabetics

Think those few extra pounds might help you get through sickness? Think again. A new study shows they actually do more harm that good. “We don’t see any positive effect at all,” Deirdre Tobias, with the Harvard School of Public Health told Bloomberg. The bottom line is that being overweight increases your likelihood of heart disease, cancer and premature death. About two-thirds of U.S. adults are overweight, and a third of them are obese. Many of those who are overweight also have type 2 diabetes, a condition in which the body does not produce enough insulin to regulate blood sugar ... Read More

Rise in obesity rates puts more people at risk of serious health consequences

An estimated one-third of the world’s adult population is overweight or obese and at risk of developing diabetes and other serious health conditions, according to a new study by the Overseas Development Institute (ODI). “The evidence is well established: obesity, together with excessive consumption of fat and salt, is linked to the rising global incidence of non-communicable diseases including some cancers, diabetes, heart disease, and strokes,” the report states. The study found the biggest problem to be in developing countries, where an estimated 900 million are considered overweight – nearly three times as many as 1980. Comparatively, about 550 million ... Read More

Obese people can cut heart disease, stroke risk by lowering cholesterol, blood pressure, blood sugar

Obese and overweight people who lower their blood pressure, cholesterol and blood sugar levels could cut their risk of heart disease and stroke by more than half, according to a new study published in The Lancet. Researchers analyzed nearly 100 studies that involved more than 1.8 million people worldwide. They concluded that high blood pressure, cholesterol and blood sugar levels contributed to about 50 percent of overweight and obese people’s increased risk of heart disease and 75 percent of their increased risk of stroke. Obesity rates have almost doubled worldwide in the past 35 years affecting more than 1.4 billion ... Read More

Diet pill Qsymia may reduce risk of type 2 diabetes in obese patients

Obese patients who took the new weight loss drug Qsymia were more than 70 percent less likely to develop type 2 diabetes compared to patients who were taking a placebo, according to a late-stage clinical trial. Type 2 diabetes is a chronic condition in which the body does not produce any or enough insulin, causing unstable blood sugar levels. Being overweight significantly increases the risk of developing the disease. Qsymia was approved last year and became the first weight loss pill to be approved for sale in the United States in 13 years. The drug is intended for people with a ... Read More

Lipitor may protect against gum disease but increases blood sugar levels

A high dose of the widely prescribed cholesterol-lowering statin atorvastatin, known by the brand name Lipitor, may help alleviate periodontal disease, a small, randomized study suggests. However, other studies have shown Lipitor puts users at risk for type 2 diabetes, a condition that if not properly controlled can lead to gum disease. Periodontal disease is a gum disease that affects nearly half of U.S. adults. It has been associated with atherosclerosis, or hardening of the arteries in some studies although more recent studies have questioned the connection. The possible connection between atherosclerosis and gum disease comes from the type of ... Read More

Novo Nordisk testing higher doses of Victoza as weight loss drug for obese diabetics

Novo Nordisk is hoping data from a phase III trial involving a higher dosage of its type 2 diabetes drug Victoza (liraglutide) will show it can help overweight and obese people with the chronic disease lose weight. The first of three studies in the pharmaceutical company’s SCALE clinical program showed promising results. Patients given a high (3mg) dose achieved a 6 percent reduction in weight compared to a 2 percent reduction in patients taking a placebo. Victoza is already approved in 1.8 mg dosage, and previous studies have shown the drug can reduce weight in patients by 5 percent. The ... Read More